Similar to This
Previous
GSK advancing ovarian cancer drug mo-rez: Today's biotech news includes Revolution Medicines 'unprecedented' cancer trial data ...
statnews.com/2026/04/13/biotech-news-gsk-advacing-ovarian-cancer-drug-mo-rez/

Paid articlePaywallAllogene's blood cancer therapy cuts risk of cancer relapse in mid-stage study: Allogene Therapeutics said on Monday that interim data from a mid-stage study ...
reuters.com/business/healthcare-pharmaceuticals/allogenes-blood-cancer-therapy-delays-cancer-relapse-mid-stage-study-2026-04-13/

Allogene Therapeutics’ CAR-T treatment eliminates residual cancer cells in B-cell lymphoma patients
statnews.com/2026/04/13/allogene-therapeutics-car-t-treatment-eliminates-cancer-cells-b-cell-lymphoma/

Paid articlePaywallThe biotech scorecard for the second quarter: 23 stock-moving events to watch: Here's a look at top trial readouts and FDA approval decisions on drugs from ...
statnews.com/2026/04/01/biotech-scorecard-second-quarter/

Paid articlePaywallEli Lilly’s deal man, Allogene’s off-the-shelf CAR-T, and Merck’s Terns buy: This week on the podcast: Lilly’s Jake van Naarden is very, very busy ...
statnews.com/2026/03/26/eli-lilly-allogene-merck-terns-readout-loud-podcast/

Allogene’s off-the-shelf CAR-T is nearing an early but pivotal study readout: In this week's edition of "Adam's Biotech Scorecard ...
statnews.com/2026/03/26/allogene-car-t-lymphoma-treatment-study/

Paid articlePaywallDenali Therapeutics, Corcept Therapeutics win FDA approvals: Today's biotech news includes the FDA giving the green light to Denali's Hunter syndrome ...
statnews.com/2026/03/26/denali-corcept-fda-allogene-car-t-readout-newsletter/

Paid articlePaywallKeratoconus: allogeneic corneal stroma implant with good results - | Deutsches Ärzteblatt
aerzteblatt.de/news/keratokonus-allogenes-hornhautstromaimplantat-mit-guten-ergebnissen-63c45214-1a68-4fbe-9e58-3d8b87b6ac7d

Next
